{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:26:58Z","timestamp":1769282818259,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1111\/bjd.18047","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T15:35:49Z","timestamp":1556206549000},"page":"690-697","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Persistence of apremilast in moderate\u2010to\u2010severe psoriasis: a real\u2010world analysis of 14 147 apremilast\u2010 and methotrexate\u2010naive patients in the French National Health Insurance database"],"prefix":"10.1093","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-5270","authenticated-orcid":false,"given":"E.","family":"Sbidian","sequence":"first","affiliation":[{"name":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"},{"name":"AP\u2010HP, H\u00f4pitaux Universitaires Henri Mondor D\u00e9partement de Dermatologie Universit\u00e9 Paris\u2010Est Cr\u00e9teil Cr\u00e9teil F\u201094010 France"},{"name":"INSERM Centre d'Investigation Clinique 1430 Cr\u00e9teil F\u201094010 France"},{"name":"EA 7379 EpidermE Universit\u00e9 Paris\u2010Est Cr\u00e9teil Cr\u00e9teil F\u201094010 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Billionnet","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Weill","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Maura","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mezzarobba","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'Etudes en Sant\u00e9 Publique Direction de la Strat\u00e9gie des Etudes et des Statistiques, Caisse Nationale d'Assurance Maladie des Travailleurs Salari\u00e9s (CNAM) Paris F\u201075020 France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7"},{"key":"e_1_2_6_3_1","unstructured":"U.S. Food and Drug Administration.Drugs@FDA: FDA approved drug products. Available at:https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=206088(last accessed 12 June 2019)."},{"key":"e_1_2_6_4_1","unstructured":"European Medicines Agency.Otezla. Available at:https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/otezla(last accessed 12 June 2019)."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.049"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14164"},{"key":"e_1_2_6_7_1","unstructured":"National Institute for Health and Care Excellence.Apremilast for treating moderate to severe plaque psoriasis. Available at:https:\/\/www.nice.org.uk\/guidance\/TA419\/chapter\/1-Recommendations(last accessed 12 June 2019)."},{"key":"e_1_2_6_8_1","unstructured":"Haute Autorit\u00e9 de Sant\u00e9.Otezla (apr\u00e9milast) immunosuppresseur inhibiteur de PDE4. Available at:https:\/\/www.has-sante.fr\/portail\/jcms\/c_2585408\/fr\/otezla-apremilast-immunosuppresseur-inhibiteur-de-pde4(last accessed 12 June 2019)."},{"key":"e_1_2_6_9_1","unstructured":"CADTH.Apremilast. Available at:https:\/\/www.cadth.ca\/apremilast-6(last accessed 12 June 2019)."},{"key":"e_1_2_6_10_1","first-page":"CD011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta\u2010analysis","volume":"12","author":"Sbidian E","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.05.040"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08315.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.052"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14738"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39553.670231.25"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.208"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16809"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2002"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2017.05.004"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckq108"},{"key":"e_1_2_6_21_1","first-page":"CD005028","article-title":"Topical treatments for chronic plaque psoriasis","volume":"2013","author":"Mason AR","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_22_1","unstructured":"World Health Organization Centre for Drug Statistics Methodology.Definition and general considerations. Available at:https:\/\/www.whocc.no\/ddd\/definition_and_general_considera(last accessed 12 June 2019)."},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1673"},{"key":"e_1_2_6_24_1","unstructured":"MeyersJ.newsurv. Available at:http:\/\/www.sascommunity.org\/mwiki\/images\/d\/d7\/Newsurv_sgf.sas(last accessed 12 June 2019)."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.028"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15061"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14617"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418755982"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14832"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.1254"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.04.043"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13682"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13831"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12876"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13616"},{"key":"e_1_2_6_36_1","first-page":"CD009481","article-title":"Narrow\u2010band ultraviolet B phototherapy versus broad\u2010band ultraviolet B or psoralen\u2010ultraviolet A photochemotherapy for psoriasis","volume":"2013","author":"Chen X","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/JID.2015.350"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2017.03.012"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17104"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.18047","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18047","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.18047","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:49:18Z","timestamp":1676382558000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/182\/3\/690\/6731507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1111\/bjd.18047"],"URL":"https:\/\/doi.org\/10.1111\/bjd.18047","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"2019-04-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}